-
Symbol
-
BBOT on Nasdaq
-
Investment type
-
Equity / COMMON STOCK
-
Latest Disclosed Shares Owned
-
4,885,446 shares
-
Security Ownership %
-
6.2%
Deerfield Management Company, L.P. ownership in BridgeBio Oncology Therapeutics, Inc. COMMON STOCK (BBOT)
18 Aug 2025 - Deerfield Management Company, L.P. has filed an SCHEDULE 13G form with the Securities and Exchange Commission (SEC) disclosing ownership of 4,885,446 shares of BridgeBio Oncology Therapeutics, Inc. COMMON STOCK (BBOT).
This represents 6.2% ownership of the company.
This is the first filing by James E. Flynn disclosing ownership of BridgeBio Oncology Therapeutics, Inc. COMMON STOCK (BBOT).